Across TCGA pan-cancer cohorts, OR2W4P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated OR2W4P data layer.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher OR2W4P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR2W4P expression acts as an unfavorable survival marker.
BRCA, KIRP, and DLBC are the cancer types where OR2W4P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.